Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ-Reference-Cited by-同舟云学术

Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ

Published:2017-04-25 Issue:3 Volume:361 Page:429-440
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Allen Rodger A.,Brookings Daniel C.,Powell Mark J.,Delgado Jean,Shuttleworth Lindsay K.,Merriman Mark,Fahy Ian J.,Tewari Roohi,Silva John P.,Healy Louise J.,Davies Gareth C. G.,Twomey Breda,Cutler Rona M.,Kotian Apoorva,Crosby Andrea,McCluskey Gillian,Watt Gillian F.,Payne Andrew

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference50 articles.

1. Requirement for Phosphoinositide 3-Kinase p110δ Signaling in B Cell Antigen Receptor-Mediated Antigen Presentation

2. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response

3. Isoform-Specific Functions of Phosphoinositide 3-Kinases: p110δ but Not p110γ Promotes Optimal Allergic Responses In Vivo

4. Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage

5. The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N‐Pyridylureas as Masked Isocyanates Fort the Late‐Stage Diversification of Pyridine‐N‐Oxides;ChemistrySelect;2024-03-27

2. Quinoline: A versatile bioactive scaffold and its molecular hybridization;Results in Chemistry;2024-01

3. PI3Kδ Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3Kδ Syndrome and Beyond;The Journal of Allergy and Clinical Immunology: In Practice;2024-01

4. Design, synthesis and bioactivity evaluation of selenium-containing PI3Kδ inhibitors;Bioorganic Chemistry;2023-11

5. Discovery of novel pyrido[3,2‐d]pyrimidine derivatives as selective and potent PI3Kδ inhibitors;Drug Development Research;2023-09-21